9 ноя 2020 г. - The FDA grants an EUA for Eli Lilly’s monoclonal antibody treatment, bamlanivimab. Lilly showed that hospitalizations in COVID-19 patients decreased within 28 days, indicating that it prevents severe forms of the disease when administered quickly.

Добавлено на ленту времени:

COVID 2020 - Policy, vaccines, therapies, and testing

ByMedicalGold.ca

16 сен 2021

0

0

585

Дата: